Biopharma and MedTech half year review 2021

Evaluate Vantage’s latest half-year report, examines the emerging trends shaping thebiopharma and medtech sectors. Winners and losers on the stock market are identified; developers thatbrought pandemic treatments or vaccines to market are reaping the benefits, while in medtech those makingdevices used in orthopaedics or cardiovascular procedures are surging back.